Hypertension

Research results presented at HFSA 2016 support switching from conventional treatment approaches to the new combination treatment.

A presentation at the 2016 Heart Failure Society of America Scientific Meeting provided details on serelaxin, ularitide, and other new therapies for heart failure.

One nephrologist's thoughts on where in the annals of hypertension trials the SPRINT results may settle.

There is a known connection between atrial fibrillation and stroke risk. Finding the best way to handle this connection can determine the success of care and the quality of life for patients.

There are many factors which can contribute to a patient developing Alzheimer's which goes beyond proteins which may be found in the brain.

The development of new novel oral anticoagulants has made a definite impact in the field in a short period of time. Work is being done to bring reversal agents into the field which can work with these new medications.

Since the days when Warfarin was the lone option in anticoagulants a considerable amount of research has been conducted leading to the development of new novel oral anticoagulants.

In the United States the availability of the latest technology can vary depending on geographic locations in some cases. This can be a greater problem for service members stationed around the world.

Cardiac CT scans can be important in diagnosing various conditions but may not be appropriate for all cardiologists to perform. As a result, with specialized training the results can be dramatically improved to help both civilian and military patients.

At Walter Reed National Military Medical Center there is an extra focus in ensuring tests are accurate for service members either before deploying or when they return home. As a result they have made a concerted effort to improve several tests including cardiac CT.

A trial of 3 automated blood pressure cuffs indicates that two of the devices provide reasonably accurate readings for patients with atrial fibrillation (AF).

Dr Bobby Lazzara reviews a first-of-its-kind study that found aerobic capacity second only to smoking as a predictor of death.

While some patients may need procedures like gastric bypass surgery to lose weight others may be able to achieve their goals by taking smaller steps.

After years of hearing they need to exercise and lose weight some patients can lose the purpose of the message and the potential benefits that come with it.

For patients needing to lose the most amount of weight for help with cardiovascular conditions or diabetes there are many ideas on how best to achieve their goals.

In addition to new medications there are new devices and procedures constantly being developed to help patients across a broad spectrum of conditions. Data from these trials can determine how helpful they are for patients and what their future usage will be.

As newer medications are developed for various conditions there can be a rush to prescribe them for patients. However, various factors including cost can make these prohibitive options for doctors and patients alike.

As transcatheter aortic valve replacement (or TAVR) becomes more common, more work is being done to help patients undergoing this procedure.

How many US adults are considered eligible for SPB equal to/less than 120 mm Hg? What about those who aren't?

With a new armamentarium of medications, procedures, and operations patients with any number of cardiac conditions are seeing their quality of lives improve dramatically for considerably longer.

As the field of cardiology advances new procedures are being developed to help patients in more effective methods. The SCOUT trial looked at one potential treatment to help patients with tricuspid regurgitation.